Overview
Kristin Rathje practices in Hamburg, Germany. Ms. Rathje is rated as an Experienced expert by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Myelofibrosis, Splenomegaly, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Graft.
Her clinical research consists of co-authoring 23 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Myelodysplastic Syndrome (MDS).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Bone Marrow TransplantMs. Rathje isAdvanced. Learn about Bone Marrow Transplant.
- Graft Versus Host Disease (GvHD)Ms. Rathje isAdvanced. Learn about Graft Versus Host Disease (GvHD).
- MyelofibrosisMs. Rathje isAdvanced. Learn about Myelofibrosis.
- SplenomegalyMs. Rathje isAdvanced. Learn about Splenomegaly.
- Experienced
- Bone GraftMs. Rathje isExperienced. Learn about Bone Graft.
- Chronic Myelomonocytic Leukemia (CMML)Ms. Rathje isExperienced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Multiple MyelomaMs. Rathje isExperienced. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Ms. Rathje isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- Neurotoxicity SyndromesMs. Rathje isExperienced. Learn about Neurotoxicity Syndromes.
- Relapsed Refractory Multiple Myeloma (RRMM)